| Year |
Citation |
Score |
| 2023 |
Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R, Tran W, Yang HT, Wang Y, Xu Y, Obusan MB, ... ... Champhekar A, et al. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proceedings of the National Academy of Sciences of the United States of America. 120: e2221116120. PMID 37192158 DOI: 10.1073/pnas.2221116120 |
0.442 |
|
| 2022 |
Monticone G, Huang Z, Csibi F, Leit S, Ciccone D, Champhekar AS, Austin JE, Ucar DA, Hossain F, Ibba SV, Boulares AH, Carpino N, Xu K, Majumder S, Osborne BA, et al. Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses. Frontiers in Immunology. 13: 987298. PMID 36090975 DOI: 10.3389/fimmu.2022.987298 |
0.391 |
|
| 2020 |
Grasso CS, Tsoi J, Onyshchenko M, Abril-Rodriguez G, Ross-Macdonald P, Wind-Rotolo M, Champhekar A, Medina E, Torrejon DY, Shin DS, Tran P, Kim YJ, Puig-Saus C, Campbell K, Vega-Crespo A, et al. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. Cancer Cell. PMID 32916126 DOI: 10.1016/J.Ccell.2020.08.005 |
0.441 |
|
| 2020 |
Torrejon DY, Abril-Rodriguez G, Champhekar AS, Tsoi J, Campbell KM, Kalbasi A, Parisi G, Zaretsky JM, Garcia-Diaz A, Puig-Saus C, Cheung-Lau G, Wohlwender T, Krystofinski P, Vega-Crespo A, Lee CM, et al. Overcoming genetically-based resistance mechanisms to PD-1 blockade. Cancer Discovery. PMID 32467343 DOI: 10.1158/2159-8290.CD-19-1409 |
0.31 |
|
| 2019 |
Torrejon DY, Abril-Rodriguez G, Tsoi J, Champhekar A, Kalbasi A, Campbell KM, Parisi G, Puig-Saus C, Cheung-Lau G, Wohlwender T, Berent-Maoz B, Grasso C, Comin-Anduix B, Hu-Lieskovan S, Ribas A. Overcoming genetically based resistance mechanisms to PD-1 blockade. Journal of Clinical Oncology. 37: 2584-2584. DOI: 10.1200/Jco.2019.37.15_Suppl.2584 |
0.325 |
|
| 2018 |
Puig-Saus C, Parisi G, Garcia-Diaz A, Krystofinski PE, Sandoval S, Zhang R, Champhekar AS, McCabe J, Cheung-Lau GC, Truong NA, Vega-Crespo A, Komenan MDS, Pang J, Macabali MH, Saco JD, et al. IND-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30409823 DOI: 10.1158/1078-0432.Ccr-18-0963 |
0.631 |
|
| 2016 |
Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, et al. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. Plos Pathogens. 12: e1005356. PMID 26808628 DOI: 10.1371/Journal.Ppat.1005356 |
0.547 |
|
| 2016 |
Rothenberg EV, Ungerbäck J, Champhekar A. Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control. Advances in Immunology. 129: 109-74. PMID 26791859 DOI: 10.1016/Bs.Ai.2015.09.002 |
0.832 |
|
| 2015 |
Champhekar A, Damle SS, Freedman G, Carotta S, Nutt SL, Rothenberg EV. Regulation of early T-lineage gene expression and developmental progression by the progenitor cell transcription factor PU.1. Genes & Development. 29: 832-48. PMID 25846797 DOI: 10.1101/Gad.259879.115 |
0.87 |
|
| 2014 |
Scripture-Adams DD, Damle SS, Li L, Elihu KJ, Qin S, Arias AM, Butler RR, Champhekar A, Zhang JA, Rothenberg EV. GATA-3 dose-dependent checkpoints in early T cell commitment. Journal of Immunology (Baltimore, Md. : 1950). 193: 3470-91. PMID 25172496 DOI: 10.4049/Jimmunol.1301663 |
0.778 |
|
| 2013 |
Rothenberg EV, Champhekar A, Damle S, Del Real MM, Kueh HY, Li L, Yui MA. Transcriptional establishment of cell-type identity: dynamics and causal mechanisms of T-cell lineage commitment. Cold Spring Harbor Symposia On Quantitative Biology. 78: 31-41. PMID 24135716 DOI: 10.1101/Sqb.2013.78.020271 |
0.488 |
|
| 2013 |
Kueh HY, Champhekar A, Champhekhar A, Nutt SL, Elowitz MB, Rothenberg EV. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science (New York, N.Y.). 341: 670-3. PMID 23868921 DOI: 10.1126/Science.1240831 |
0.763 |
|
| 2008 |
Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, Fauq A, Das P, Golde TE, Osborne BA. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood. 112: 1813-21. PMID 18550850 DOI: 10.1182/Blood-2008-03-144980 |
0.83 |
|
| Show low-probability matches. |